公司概述
Magnera Corporation is a global manufacturer and distributor of non-woven products that serves primarily the healthcare and personal care consumer-oriented end markets. Operating within the Consumer Defensive sector and the Household & Personal Products industry, the company supplies essential components for medical applications and consumer solutions. As of the latest data, the entity holds a market capitalization of $355.64M and generates annual revenue of $3.29B, employing a workforce of 8500 individuals. These financial figures indicate that while Magnera operates as a significant player in its niche with substantial revenue generation, its market valuation reflects a mid-cap profile rather than a large-cap industry leader.
财务健康
The company reported a Total Revenue of $3.29B over the trailing twelve months, yet it recorded a Net Income of -$133,000,000, while maintaining an EBITDA of $322.00M. The substantial gap between the $3.29B revenue and the -$133M net income reveals a significant cost structure burden, where operating expenses, interest, or other non-operating charges exceed total earnings before interest and taxes. Despite the reported net loss, the business generated Free Cash Flow of $172.12M, which provides a critical buffer for financial flexibility and operational resilience. The Gross Margin stands at 11.0%, indicating that the core manufacturing and sales operations retain a modest portion of revenue after direct costs. The Operating Margin of 4.5% suggests that overhead costs consume a large percentage of gross profits before interest and taxes. The Profit Margin of -4.0% confirms that the company is currently posting a net loss on the bottom line after all expenses. In terms of liquidity and leverage, the company holds $264.00M in cash against total debt of $1.99B, resulting in a Debt to Equity ratio of 192.00, which characterizes the balance sheet as highly leveraged. The Current Ratio of 2.46 indicates that the company possesses sufficient current assets to cover its short-term liabilities comfortably. Return on Equity is recorded at -12.4% and Return on Assets is 1.9%, metrics that respectively reveal that shareholder equity is being eroded by losses while assets generate a minimal positive return on the book value.
估值评估
The valuation metrics present a complex picture with a Trailing P/E Ratio of N/A due to the negative earnings, while the Forward P/E is calculated at 10.63. The discrepancy between a negative trailing P/E and a specific forward P/E implies that the market expects a significant turnaround in earnings trajectory to achieve positive profitability in the near future. The Price to Book ratio is 0.35, which indicates that the market values the company at a significant discount to its tangible book value, suggesting a lack of market premium over assets. Alternative valuation metrics such as the Price to Sales ratio of 0.11 and an EV/EBITDA of 6.48 suggest that the stock is priced on a low multiple of its sales and earnings power relative to peers. The stock has traded within a 52-week range between a high of $16.44 and a low of $7.82, with the current implied valuation sitting at a discount relative to the recent high. The Beta value is N/A, which limits the ability to quantify price volatility relative to the broader market using standard statistical measures.
Growth & Income
The company demonstrated Revenue Growth of 12.8% year-over-year, whereas the Earnings Growth is N/A due to the reported net loss. Since earnings are negative, they are not growing faster than revenue; instead, the expansion in revenue has not yet translated into bottom-line profitability, implying a need for cost optimization or volume scaling. As a non-dividend payer, the company does not distribute a Dividend Yield, which is N/A, nor does it maintain a Payout Ratio of 0.0%. Consequently, the company is not paying dividends to shareholders but is instead retaining earnings, although currently resulting in a loss, to reinvest into growth initiatives. The overall growth and income profile is characterized by double-digit revenue expansion paired with a lack of current dividend income and negative earnings per share.
同行比较
Magnera Corporation (MAGN) 在家庭与个人护理产品行业运营。以下是其与市值最接近的同行的比较:
家庭与个人护理产品行业平均市盈率为29.9倍。Magnera Corporation的市盈率为N/A。